Zacopride stimulates 5-HT4 serotonin receptors in the human atrium
Open Access
- 1 April 2024
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 397 (9) , 6821-6835
Abstract
Zacopride (4-amino-5-chloro-2-methoxy-N-(quinuclidin-3-yl)-benzamide) is a potent agonist in human 5-HT4 serotonin receptors in vitro and in the gastrointestinal tract. Zacopride was studied as an antiemetic drug and was intended to treat gastric diseases. Zacopride has been speculated to be useful as an antiarrhythmic agent in the human ventricle by inhibiting cardiac potassium channels. It is unknown whether zacopride is an agonist in human cardiac 5-HT4 serotonin receptors. We tested the hypothesis that zacopride stimulates human cardiac atrial 5-HT4 serotonin receptors. Zacopride increased the force of contraction and beating rate in isolated atrial preparations from mice with cardiac-specific overexpression of human 5-HT4 serotonin receptors (5-HT4-TG). However, it was inactive in wild-type mouse hearts (WT). Zacopride was as effective as serotonin in raising the force of contraction and beating rate in atrial preparations of 5-HT4-TG. Zacopride raised the force of contraction in human right atrial preparations (HAP) in the absence and presence of the phosphodiesterase III inhibitor cilostamide (1 µM). The positive inotropic effect of zacopride in HAP was attenuated by either 10 µM tropisetron or 1 µM GR125487, both of which are antagonists at 5-HT4 serotonin receptors. These data suggest that zacopride is also an agonist at 5-HT4 serotonin receptors in the human atrium.Keywords
Funding Information
- Martin-Luther-Universität Halle-Wittenberg
This publication has 36 references indexed in Scilit:
- Lysergic acid diethylamide stimulates cardiac human H2 histamine and cardiac human 5-HT4-serotonin receptorsNaunyn-Schmiedeberg's Archives of Pharmacology, 2023
- Which phosphodiesterase can decrease cardiac effects of 5-HT4 receptor activation in transgenic mice?Naunyn-Schmiedeberg's Archives of Pharmacology, 2019
- Cardiovascular effects of cisapride and prucalopride on human 5-HT4 receptors in transgenic miceNaunyn-Schmiedeberg's Archives of Pharmacology, 2018
- A Singular Role of IK1 Promoting the Development of Cardiac Automaticity during Cardiomyocyte Differentiation by IK1 –Induced Activation of Pacemaker CurrentStem Cell Reviews and Reports, 2017
- Human 5-HT4 receptor stimulation in atria of transgenic miceNaunyn-Schmiedeberg's Archives of Pharmacology, 2013
- Phosphorylation of phospholamban and troponin I through 5-HT4 receptors in the isolated human atriumNaunyn-Schmiedeberg's Archives of Pharmacology, 2008
- Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failureNaunyn-Schmiedeberg's Archives of Pharmacology, 2004
- Targeted Overexpression of Phospholamban to Mouse Atrium Depresses Ca2+Transport and ContractilityJournal of Molecular and Cellular Cardiology, 1998
- Identification of putative 5-HT4 receptors in guinea-pig ascending colonEuropean Journal of Pharmacology, 1991
- The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neuronsNaunyn-Schmiedeberg's Archives of Pharmacology, 1989